| Announce Date | 11/05/2025 |
| EPS Normalized Actual | $11.17 (Beat by $3.62) |
| EPS GAAP Actual | $11.17 (Beat by $3.62) |
| Revenue Actual | $16.633B |
| Revenue Surprise | Beat by $16633M |
| Announce Date | 12/30/2025 (Pre-Market) |
| EPS Normalized Estimate | $7.22841 |
| EPS GAAP Estimate | $7.22841 |
| Revenue Estimate | $14.76863939B |
| Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
|---|---|---|---|---|---|
| Dec 2026 | 0 | INF | 0 | 0 | 0 |
| Dec 2025 | 0 | INF | 0 | 0 | 0 |
| Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
|---|---|---|---|---|---|
| FQ2 2025 (Jun 2025) | 0 | 0 | 16.633B | 5.53% | -51.25M |
| FQ1 2025 (Mar 2025) | 0 | 0 | 16.452B | 7.25% | 131.18M |
| FQ4 2024 (Dec 2024) | 0 | 0 | 16.506B | 10.14% | 229.62M |
| FQ3 2024 (Sep 2024) | 4.39 | 4.39 | 16.627B | 20.56% | 16627M |
| FQ2 2024 (Jun 2024) | 0 | 0 | 15.714B | 11.04% | 15714M |
| FQ1 2024 (Mar 2024) | 0 | 0 | 15.259B | 19.15% | 15259M |
| FQ4 2023 (Dec 2023) | 0 | 0 | 14.832B | 7.99% | 14832M |
| FQ3 2023 (Sep 2023) | -0.16 | -0.16 | 13.208B | 0% | 13208M |
FQ4 Announce Date
12/30/2025 (Pre-Market)
Consensus EPS Estimates
7.22841
Consensus Revenue Estimates
14.76863939B
| Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2027 (Dec 2027) | 8.21243 | -- | 7.95757 | 8.46729 | 1 |
| FQ3 2027 (Sep 2027) | 5.30847 | -- | 5.21437 | 5.40257 | 1 |
| FQ2 2027 (Jun 2027) | 3.15583 | -- | 3.09989 | 3.21177 | 1 |
| FQ1 2027 (Mar 2027) | 6.60115 | -- | 6.39629 | 6.80601 | 1 |
| FQ4 2026 (Dec 2026) | 7.64475 | -- | 7.40751 | 7.88199 | 1 |
| FQ3 2026 (Sep 2026) | 4.66429 | -- | 4.58161 | 4.74697 | 1 |
| FQ2 2026 (Jun 2026) | 3.23726 | -- | 3.17987 | 3.29465 | 1 |
| FQ1 2026 (Mar 2026) | 6.52793 | -- | 6.32535 | 6.73051 | 1 |
| FQ4 2025 (Dec 2025) | 7.22841 | -- | 7.00409 | 7.45273 | 1 |
| Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2027 (Dec 2027) | 17.23B | -- | 16.82B | 17.64B | 1 |
| FQ3 2027 (Sep 2027) | 18.59B | -- | 18.34B | 18.85B | 1 |
| FQ2 2027 (Jun 2027) | 17.94B | -- | 17.69B | 18.18B | 1 |
| FQ1 2027 (Mar 2027) | 16.51B | -- | 16.11B | 16.9B | 1 |
| FQ4 2026 (Dec 2026) | 15.81B | -- | 15.43B | 16.19B | 1 |
| FQ3 2026 (Sep 2026) | 17.19B | -- | 16.96B | 17.43B | 1 |
| FQ2 2026 (Jun 2026) | 16.64B | 0.03 | 16.41B | 16.86B | 1 |
| FQ1 2026 (Mar 2026) | 15.22B | -8.1 | 14.86B | 15.58B | 1 |
| FQ4 2025 (Dec 2025) | 14.77B | -11.76 | 14.38B | 15.15B | 2 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
1
EPS # of Misses
1
EPS # of in-lines
6
Revenue # of Beats
7
Revenue # of Misses
1
Revenue # of in-lines
0
| Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ2 2025 (Jun 2025) | 0 | 0 | 0 | NAN% |
| FQ1 2025 (Mar 2025) | 0 | 0 | 0 | NAN% |
| FQ4 2024 (Dec 2024) | 0 | 0 | 0 | NAN% |
| FQ3 2024 (Sep 2024) | 4.39 | 4.39 | 100% | |
| FQ2 2024 (Jun 2024) | 0 | 0 | NAN% | |
| FQ1 2024 (Mar 2024) | 0 | 0 | NAN% | |
| FQ4 2023 (Dec 2023) | 0 | 0 | NAN% | |
| FQ3 2023 (Sep 2023) | -0.16 | -0.16 | 100% |
| Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ2 2025 (Jun 2025) | $16.68B | $16.63B | $-51.25M | -0.31% |
| FQ1 2025 (Mar 2025) | $16.32B | $16.45B | $131.18M | 0.8% |
| FQ4 2024 (Dec 2024) | $16.28B | $16.51B | $229.62M | 1.39% |
| FQ3 2024 (Sep 2024) | $0B | $16.63B | $16627M | 100% |
| FQ2 2024 (Jun 2024) | $0B | $15.71B | $15714M | 100% |
| FQ1 2024 (Mar 2024) | $0B | $15.26B | $15259M | 100% |
| FQ4 2023 (Dec 2023) | $0B | $14.83B | $14832M | 100% |
| FQ3 2023 (Sep 2023) | $0B | $13.21B | $13208M | 100% |